Adhera Therapeutics, Inc.

OTCPK:ATRX Stock Report

Market Cap: US$27.9k

Adhera Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4.3yrs

Recent management updates

Recent updates

CEO

Adhera Therapeutics has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Andrew Kucharchuk
Vice Chairman4.3yrsUS$285.00kno data
Andrew Reaume
Member of Scientific Advisory Boardno datano datano data
Charles Rice
Independent Director4.3yrsUS$24.00kno data
Jean Buteau
Chairman of Scientific Advisory Board2.7yrsno datano data

4.3yrs

Average Tenure

Experienced Board: ATRX's board of directors are considered experienced (4.3 years average tenure).